• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 X 染色体失活选择,从一名鸟氨酸转氨甲酰酶缺乏症的女性患者中诱导出健康的肝细胞样细胞。

Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection.

机构信息

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.

Biochemistry and Molecular Biology Department, Universidad de Valencia, Valencia, Spain.

出版信息

Sci Rep. 2022 Feb 10;12(1):2308. doi: 10.1038/s41598-022-06184-w.

DOI:10.1038/s41598-022-06184-w
PMID:35145162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8831560/
Abstract

Autologous cell replacement therapy for inherited metabolic disorders requires the correction of the underlying genetic mutation in patient's cells. An unexplored alternative for females affected from X-linked diseases is the clonal selection of cells randomly silencing the X-chromosome containing the mutant allele, without in vivo or ex vivo genome editing. In this report, we have isolated dermal fibroblasts from a female patient affected of ornithine transcarbamylase deficiency and obtained clones based on inactivation status of either maternally or paternally inherited X chromosome, followed by differentiation to hepatocytes. Hepatocyte-like cells derived from these clones display indistinct features characteristic of hepatocytes, but express either the mutant or wild type OTC allele depending on X-inactivation pattern. When clonally derived hepatocyte-like cells were transplanted into FRG KO mice, they were able to colonize the liver and recapitulate OTC-dependent phenotype conditioned by X-chromosome inactivation pattern. This approach opens new strategies for cell therapy of X-linked metabolic diseases and experimental in vitro models for drug development for such diseases.

摘要

自体细胞替代疗法治疗遗传性代谢疾病需要纠正患者细胞中潜在的基因突变。对于 X 连锁疾病的女性患者,一种尚未被探索的替代方法是随机选择沉默携带突变等位基因的 X 染色体的细胞进行克隆选择,而无需体内或体外基因组编辑。在本报告中,我们从一名患有鸟氨酸转氨甲酰酶缺乏症的女性患者中分离出皮肤成纤维细胞,并根据母源或父源 X 染色体失活状态获得克隆,然后分化为肝细胞。这些克隆衍生的类肝细胞表现出明显不同于肝细胞的特征,但根据 X 染色体失活模式表达突变型或野生型 OTC 等位基因。当克隆衍生的类肝细胞被移植到 FRG KO 小鼠中时,它们能够定植于肝脏,并重现由 X 染色体失活模式决定的 OTC 依赖性表型。这种方法为 X 连锁代谢疾病的细胞治疗和此类疾病的药物开发提供了新的实验体外模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/0fef292f3a39/41598_2022_6184_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/8d4b6f0b00a0/41598_2022_6184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/0e218cb84471/41598_2022_6184_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/0fef292f3a39/41598_2022_6184_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/8d4b6f0b00a0/41598_2022_6184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/0e218cb84471/41598_2022_6184_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4de/8831560/0fef292f3a39/41598_2022_6184_Fig3_HTML.jpg

相似文献

1
Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection.通过 X 染色体失活选择,从一名鸟氨酸转氨甲酰酶缺乏症的女性患者中诱导出健康的肝细胞样细胞。
Sci Rep. 2022 Feb 10;12(1):2308. doi: 10.1038/s41598-022-06184-w.
2
Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies.FRG 鼠中女性鸟氨酸转氨甲酰酶缺陷型原代人肝细胞 X 染色体失活偏倚的重述:开发表观遗传疗法的新系统。
Hum Gene Ther. 2023 Sep;34(17-18):917-926. doi: 10.1089/hum.2023.011. Epub 2023 Sep 11.
3
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes.经人类肝细胞体外基因编辑纠正尿素循环缺陷。
Mol Ther. 2021 May 5;29(5):1903-1917. doi: 10.1016/j.ymthe.2021.01.024. Epub 2021 Jan 21.
4
Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency.伴 OTC 缺陷杂合女性肝中 X 染色体失活的可变性和中央区谷氨酰胺合成酶区的扩大。
Virchows Arch. 2018 Jun;472(6):1029-1039. doi: 10.1007/s00428-018-2345-x. Epub 2018 Apr 6.
5
Familial lethal inheritance of a mutated paternal gene in females causing X-linked ornithine transcarbamylase (OTC) deficiency.女性中由突变的父源基因导致的X连锁鸟氨酸转氨甲酰酶(OTC)缺乏的家族性致死性遗传。
Am J Med Genet. 1997 Mar 17;69(2):177-81. doi: 10.1002/(sici)1096-8628(19970317)69:2<177::aid-ajmg12>3.0.co;2-i.
6
X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency.患有鸟氨酸转氨甲酰酶(OTC)缺乏症的显性女性肝脏中的X染色体失活模式。
Clin Genet. 1998 Oct;54(4):349-53. doi: 10.1034/j.1399-0004.1998.5440415.x.
7
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice.腺相关病毒基因疗法可纠正鸟氨酸转氨甲酰酶缺乏症,并预防老年鸟氨酸转氨甲酰酶基因敲除杂合小鼠的肝纤维化。
Mol Genet Metab. 2017 Apr;120(4):299-305. doi: 10.1016/j.ymgme.2017.02.011. Epub 2017 Mar 2.
8
Complete deletion of ornithine transcarbamylase gene confirmed by CGH array of X chromosome.通过X染色体比较基因组杂交阵列证实鸟氨酸转氨甲酰酶基因完全缺失。
J Inherit Metab Dis. 2007 Oct;30(5):813. doi: 10.1007/s10545-007-0578-y. Epub 2007 Jun 14.
9
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.一名患有严重尿素循环障碍的婴儿接受孤立性肝细胞移植。
Pediatrics. 2003 Jun;111(6 Pt 1):1262-7. doi: 10.1542/peds.111.6.1262.
10
Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation.诱导多能干细胞技术作为缺乏基因确诊的疑似鸟氨酸转氨甲酰酶缺乏症患者的诊断工具。
Mol Genet Metab Rep. 2023 Sep 6;37:101007. doi: 10.1016/j.ymgmr.2023.101007. eCollection 2023 Dec.

引用本文的文献

1
A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies.一种用于生成可用于药物毒理学研究的肝细胞样细胞的稳健重编程策略。
Stem Cell Res Ther. 2023 Apr 18;14(1):94. doi: 10.1186/s13287-023-03311-w.

本文引用的文献

1
Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia.澳大利亚新南威尔士州30年儿童先天性代谢缺陷病肝移植经验
JIMD Rep. 2021 May 4;60(1):88-95. doi: 10.1002/jmd2.12219. eCollection 2021 Jul.
2
Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma.免疫抑制剂药物减轻移植到小鼠实质内的人骨髓间充质干细胞引发的免疫反应。
Cell Transplant. 2021 Jan-Dec;30:9636897211019025. doi: 10.1177/09636897211019025.
3
The E273del variant of uncertain significance of the ornithine transcarbamylase gene - a case for reclassification.
鸟氨酸转氨甲酰酶基因意义未明的E273del变异体——重新分类的一个案例
Mol Genet Metab Rep. 2020 May 8;23:100598. doi: 10.1016/j.ymgmr.2020.100598. eCollection 2020 Jun.
4
Phenotype instability of hepatocyte-like cells produced by direct reprogramming of mesenchymal stromal cells.间质基质细胞直接重编程产生的类肝细胞的表型不稳定。
Stem Cell Res Ther. 2020 Apr 10;11(1):154. doi: 10.1186/s13287-020-01665-z.
5
Glutamine/glutamate metabolism rewiring in reprogrammed human hepatocyte-like cells.重编程的人肝细胞样细胞中谷氨酰胺/谷氨酸代谢的重排。
Sci Rep. 2019 Nov 29;9(1):17978. doi: 10.1038/s41598-019-54357-x.
6
Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector.使用单个诱导性多顺反子载体将人成纤维细胞直接转化为肝细胞。
Stem Cell Res Ther. 2019 Nov 4;10(1):317. doi: 10.1186/s13287-019-1416-5.
7
Hepatocyte transplantation, a step forward?肝细胞移植,是前进了一步吗?
J Hepatol. 2019 Jun;70(6):1049-1050. doi: 10.1016/j.jhep.2019.03.022. Epub 2019 Apr 17.
8
Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.尿素循环障碍的诊断和管理建议指南:第一版修订。
J Inherit Metab Dis. 2019 Nov;42(6):1192-1230. doi: 10.1002/jimd.12100. Epub 2019 May 15.
9
Comprehensive characterization of ureagenesis in the spf mouse, a model of human ornithine transcarbamylase deficiency, reveals age-dependency of ammonia detoxification.全面描述 spf 小鼠(人鸟氨酸转氨甲酰酶缺乏症的模型)的尿素生成,揭示了氨解毒的年龄依赖性。
J Inherit Metab Dis. 2019 Nov;42(6):1064-1076. doi: 10.1002/jimd.12068. Epub 2019 Mar 13.
10
Prolonged engraftment of transplanted hepatocytes in the liver by transient pro-survival factor supplementation using ex vivo mRNA transfection.利用体外 mRNA 转染短暂给予促生存因子补充,延长移植肝细胞在肝脏中的植入。
J Control Release. 2018 Sep 10;285:1-11. doi: 10.1016/j.jconrel.2018.06.033. Epub 2018 Jun 30.